Latest Stock Buy or Sell? Make More Informed Decisions!

ADR. Has concession with 32 year left in the lease. He likes the stock even though there were weather problems at their airports. Passenger growth 5% this year. Attractive dividend. Would not expect the run we had this year, next year.

Markets. Consumer confidence numbers today were weaker than expected. There is profit taking as we get into Q3 earnings season. The US is decoupling from the rest of the world. It is a quarter of the global GDP. China continues to decelerate. Emerging markets are worried about a downshift in commodities. You want stocks that have a range of growth possibilities ahead of them.

Focuses in high street banking. It is repairing its balance sheet. It has been bouncing around the same level about a year. It is a solid bank. British government is divesting this holding.

NFC payment though phones looks somewhat promising. V & MA are both well placed. He is watching it and looking for weakness.

Habitually rates are higher than your average life co. He likes the space because it is one of the spaces out there that benefits from the normalization of long term bonds. Expects lifecos to be amongst the best performing.

Likes it a lot, but doesn’t own it because he has a lot of healthcare. Really benefited from a pickup in volumes. Well poised to benefit from the US healthcare act.

Australian Banks. Buy now? Very, very strong banking market like Canada. They have high dividend payout ratios. Good long term investment.

(Top Pick Nov 12/13, Down 1.17%) 60% from offshore manufacturing. High quality sponsorship. Flat over the last year. Continues to like it.

(Top Pick Nov 12/13, Up 9.48%) Industry leaders. Customized dentures.

(Top Pick Nov 12/13, Up 33.81%) 60% of business is in Iberia. Then in wind farms globally. Very high quality assets. 5.8% dividend. He thinks it will be flat next year until the year after.

A pretty complex bank with a host of publically listed securities. As an international investor, don’t settle for this. The good news is in the share price.

Large Swedish manufacturer of capital goods for telcom industry. Strong balance sheet. Touch business, low margin. There are many players that are well capitalized. Emerging markets are pressuring telcos to use their own capital products producers.

Likes health care generally. He is overweight that sector. Buys it for new clients. Pipelines are good with new launches and he would feel good buy it.

Stock has had a couple of things working against it. The strong Swiss franc has really clipped its profit. Outlook going forward is not really that great. Could be flat for another year.

One of the few things in retail that does not have to compete against Wal-Mart. It is at 24 times earnings, but the visibility of forward earnings is orders of magnitude higher.